BioSpace News Archive

BeiGene (NASDAQ: BGNE; HKEX: 06160) announced today that the European Commission (EC) approved BRUKINSA® (zanubrutinib) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM) who have received at least one prior therapy or for the first-line treatment of patients unsuitable for chemo-immunotherapy.

Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies today announced the financial results for its fiscal third quarter ending September 30, 2021 and provided a corporate update.

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that management will present company overviews at the following conferences being held virtually.

Keysight Technologies, Inc. announced today that members of its management team will participate in the following investor conferences.

Endologix LLC completed enrollment in the TORUS 2 IDE clinical study (NCT04130737) in the United States.

MEI Pharma, Inc. today announced the appointment of Mr. Sujay Kango to its board of directors effective November 22, 2021.

Hologic, Inc. (Nasdaq: HOLX) will showcase its extensive portfolio of breast and skeletal health products at the 107th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 28 to Dec. 2.

ieso today announces the completion of its $53 million Series B financing round led by investment firm Morningside, with further new investment from Sony Innovation Fund and existing shareholders IP Group, Molten Ventures and Ananda Impact Ventures.

BeiGene, Ltd. today announced the commencement of an initial public offering (STAR Offering) on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange (SSE).

Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, will participate in the Evercore ISI 4th Annual HealthCONx Conference on November 30, 2021.